Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Withdrawn 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other 1Gynecologic 1

Conditions

Obesity 56Mucositis 22Polycystic Ovary Syndrome 20Neoplasms 17Sexual Dysfunction, Physiological 15Breast Neoplasms 14Dyspnea 11Head and Neck Neoplasms 10Motor Activity 8Colorectal Neoplasms 8Rectal Neoplasms 6Prostatic Neoplasms 6Diabetes Mellitus 6Stomatitis 5Pain 5Lung Neoplasms 5Constipation 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Obesity, Morbid 4Infertility 4Depression 4Colonic Neoplasms 4Xerostomia 3Weight Loss 3Pulmonary Disease, Chronic Obstructive 3Osteoporosis 3Metabolic Syndrome 3Insulin Resistance 3Heart Failure 3Eczema 3

Interventions

Naloxone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Intestinal Obstruction × Other × Clear all
NCT00020605 2018-12-13

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

National Cancer Institute (NCI)

Phase 3 Unknown
Other

Constipation, Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡